Economic evaluation of a bio-psycho-social intervention for comorbid disorders in a traumatized population in post-war Kosovo
Post-hoc economic evaluation of a bio-psycho-social intervention in post-war Kosovo from a societal perspective. Cost-effectiveness analysis, cost-utility analysis, and partial cost-benefit analysis using data from a randomized controlled trial. Thirty-four torture/war victims with comorbid conditio...
Saved in:
Published in | Journal of rehabilitation medicine Vol. 50; no. 5; pp. 444 - 450 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Sweden
Journal of Rehabilitation Medicine
08.05.2018
Medical Journals Sweden |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Post-hoc economic evaluation of a bio-psycho-social intervention in post-war Kosovo from a societal perspective.
Cost-effectiveness analysis, cost-utility analysis, and partial cost-benefit analysis using data from a randomized controlled trial.
Thirty-four torture/war victims with comorbid conditions enrolled in 2012-2013.
Participants were randomly assigned to an "intervention" and a "waiting-list" group. Changes in mental, emotional and physical health and functional impairment were assessed before and after treatment, along with increase in labour income as a proxy for productivity gain. The cost of an extra unit of effectiveness and an additional quality-adjusted life year were calculated.
The total cost per participant was €1,322 including, or €1,019 excluding, research costs. Wide variations in costs of changes in mental, emotional and physical effectiveness were demonstrated. Multidisciplinary intervention resulted in functional improvement at a cost of €10,508 per quality-adjusted life year gained. With a mean monthly income increase to €133 (18%) after intervention, the intervention cost per participant would be equal to the total increase in monthly income after 4-5 years, assuming the increased level is maintained.
Socio-economic benefit associated with quality-adjusted life year gain is shown, although the cost of an additional quality-adjusted life year is above the World Health Organization cost-effectiveness threshold. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 1650-1977 1651-2081 |
DOI: | 10.2340/16501977-2322 |